• Corpus ID: 39672429

Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.

@article{Vogelzang1980ChemotherapyFS,
  title={Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.},
  author={Nicholas J. Vogelzang and Rachel Trowbridge and D H Frenning and Athanasios Theologides and Brian J. Kennedy and David R. Kelly and Stephen L. Ewing and Gerald J. Vosika},
  journal={Cancer treatment reports},
  year={1980},
  volume={64 8-9},
  pages={
          997-1000
        }
}
Forty consecutive patients with small cell bronchogenic carcinoma were treated. The first 18 patients were treated with CCNU and doxorubicin (Adriamycin) (CA). The next 22 patients were treated with CCNU, doxorubicin, procarbazine, and vincristine (CAPO). Patient characteristics were similar. The partial plus complete response rate was 55% (ten of 18 patients) in the CA group compared to 41% (nine of 22 patients) in the CAPO group. The median survival from treatment was 28 weeks in the CA group… 
4 Citations
Etoposide: A Semisynthetic Epipodophyllotoxin Chemistry, Pharmacology, Pharmacokinetics, Adverse Effects and Use as an Antineoplastic Agent
TLDR
Etoposide is a semi‐synthetic derivative of 4'‐demethylepipodophyllotoxin, a naturally occurring compound synthesized by the North American May apple and the Indian species Podophyllum emodi Wallich that inhibits cell cycle progression at a premitotic phase (late S and G2).
Commentary 1
TLDR
The role of VP-16-213 (Etoposide; NSC 141540) in gestational choriocarcinoma and the combination of adriamycin and vincristine in advanced breast cancer.
Ergebnisse und Möglichkeiten der Behandlung beim kleinzelligen Bronchialkarzinom
Das kleinzellige Bronchialkarzinom stellt eine recht gut definierte eigenstandige Krankheitsentitat dar. Es unterscheidet sich von den nichtkleinzelligen Bronchialkarzinomen durch feingewebliche,
Current concepts in small cell carcinoma of the lung